Related Experiment Video

Updated: May 13, 2026

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease
04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

The challenges and practical considerations with optimizing neonatal pharmacotherapy

M A Turner1,2

  • 1Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.

Expert Opinion on Pharmacotherapy
|May 12, 2026
PubMed

Insights

High-quality medicine information is crucial for optimal neonatal pharmacotherapy. This requires family-centered programs, robust pharmacometrics, and multidisciplinary collaboration for effective implementation.

Area of Science:

  • Neonatal pharmacotherapy
  • Medicinal information systems
  • Clinical pharmacy

Background:

  • Optimal neonatal pharmacotherapy hinges on accessible, high-quality medicine information.
  • Current approaches need enhancement to meet the specific needs of neonates.

Purpose of the Study:

  • To outline the essential components for developing and implementing high-quality medicine information for neonatal care.
  • To emphasize the role of family-integrated care and clinical pharmacists in neonatal pharmacotherapy.

Main Methods:

  • Program design centered on patient needs and appropriate dosage forms.
  • Application of pharmacometrics and causal pathway analysis in study design.
  • Integration of family-centered care models and multidisciplinary collaboration.

Main Results:

  • Carefully designed programs, utilizing robust pharmacometrics and clear research questions, are necessary.
  • Multidisciplinary efforts and family-integrated care are key to successful implementation.
  • Well-resourced clinical pharmacists are vital for evidence-based prescribing, administration, and monitoring.

Conclusions:

  • Effective neonatal pharmacotherapy relies on high-quality medicine information systems.
  • A collaborative, family-centered approach involving clinical pharmacists is essential for improving neonatal medicine use.
Abstract

Keywords:
Neonatesclinical pharmacydrug developmentfamily integrated carepediatric extrapolation

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...